Pulmuone (017810) Fundamentals 2026 — P/E 31.0x, Revenue Analysis | SniperIQ
Pulmuone (017810) is a KR-listed Consumer Defensive company in Agricultural Farm Products with a market capitalization of ₩321.0B, trading at ₩8700.00 on the KSC. This SniperIQ fundamentals page covers Pulmuone's valuation (P/E 31.0x, P/B 1.0x), profitability (net margin 0.8%), revenue (₩3.38T in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Pulmuone's market cap?
Pulmuone (017810) has a market capitalization of approximately ₩321.0B, trading at ₩8700.00 on the KSC. Market cap moves with the live share price.
What is Pulmuone's P/E ratio?
Pulmuone's trailing twelve-month P/E ratio is 31.0x, with a price-to-book (P/B) of 1.0x. Valuation multiples are best compared with Consumer Defensive sector peers rather than read in isolation.
How profitable is Pulmuone?
Pulmuone runs a net profit margin of 0.8%, a gross margin of 23.5%, and an operating margin of 2.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Pulmuone generate?
Pulmuone reported revenue of ₩3.38T for fiscal year 2025, with net income of ₩18.1B and earnings per share (EPS) of 84.24. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Pulmuone pay a dividend?
Pulmuone offers a trailing dividend yield of about 1.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Pulmuone financially healthy?
Pulmuone carries a debt-to-equity ratio of 3.84x and a current ratio of 0.73x, with a market beta of 0.35. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Pulmuone a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Pulmuone (017810) the key facts are: market cap ₩321.0B, P/E 31.0x, revenue ₩3.38T, 52-week range 8680-18490. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Defensive peers and form your own view.
Track Pulmuone's full fundamentals live
Get Pulmuone's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.